Experiment 1055586
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | TAYLOR,S: BELT,RJ: HAAS,CD: HOOGSTRATEN,B:. (1983). PHASE I TRIAL OF INDICINE-N-OXIDE ON TWO DOSE SCHEDULES.. 51(11) |
| Amount utilized | |
| Compound isolated | |
| Disease | A PHASE I CLINICAL STUDY IN 26 PATIENTS USING AN INTERMITTENT SCHEDULE UTILIZING SINGLE DOSES REPEATED EVERY 3-4 WEEKS. MYELOSUPPRESSION IS PREDICTABLE AND REVERSIBLE. IT IS MORE SEVERE IN PATIENTS WITH HEAVY PRIOR TREATMENT. THROMBOCYTOPENIA WAS MORE SEVERE THAN LEUKOPENIA. PARTIAL RESPONSES WERE SEEN IN 4 PATIENTS, ONE WITH A MUCOEPIDERMOID CARCINOMA OF THE SALIVARY GLAND AND 3 WITH ADENOCARCINOMA OF THE COLON. PHASE II STUDIES ARE PLANNED. |
| Dose amount | 5-10 GM |
| Number | 2 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | PERSON |
| Dose expression | DOSE |